These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12043423)

  • 1. [Marketing of researchers--lack of judgment or a new trend?].
    Werkö L; Hernborg A; Liedholm H; Melander A
    Lakartidningen; 2002 Apr; 99(17):1962-3. PubMed ID: 12043423
    [No Abstract]   [Full Text] [Related]  

  • 2. [Marketing of the LIFE trial anticipates evaluation of the drug].
    Järhult B
    Lakartidningen; 2002 Apr; 99(17):1964. PubMed ID: 12043424
    [No Abstract]   [Full Text] [Related]  

  • 3. Was the LIFE trial independent?
    Vandenbroucke JP
    Lancet; 2002 Oct; 360(9340):1171; author reply 1171. PubMed ID: 12387974
    [No Abstract]   [Full Text] [Related]  

  • 4. Was the LIFE trial independent?
    Van Brabandt H
    Lancet; 2002 Oct; 360(9340):1171; author reply 1171. PubMed ID: 12387973
    [No Abstract]   [Full Text] [Related]  

  • 5. [Promoting research and graduate education by the pharmaceutical industry--scientific progress or marketing strategy?].
    Eckardt VF
    Z Gastroenterol; 1999 Jul; Suppl 2():19-27. PubMed ID: 10472695
    [No Abstract]   [Full Text] [Related]  

  • 6. 'One pill makes you larger...'. Don't be seduced by pharmaceutical companies.
    Mason DJ
    Am J Nurs; 2000 Dec; 100(12):7. PubMed ID: 11202788
    [No Abstract]   [Full Text] [Related]  

  • 7. [Has self-interest taken over ethics and morals within medicine?].
    Werkö L
    Lakartidningen; 2002 Aug; 99(35):3432-3. PubMed ID: 12362769
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse events in randomized trials: neglected, restricted, distorted, and silenced.
    Ioannidis JP
    Arch Intern Med; 2009 Oct; 169(19):1737-9. PubMed ID: 19858427
    [No Abstract]   [Full Text] [Related]  

  • 9. [The LIFE study: extensive marketing in Denmark. Suggestions to conclusions based on the study].
    Lindberg M
    Lakartidningen; 2002 May; 99(20):2324. PubMed ID: 12082955
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical advertising: from prospectus to marketing.
    Cambronero-Saiz B
    J Epidemiol Community Health; 2007 Apr; 61(4):366. PubMed ID: 17372300
    [No Abstract]   [Full Text] [Related]  

  • 11. The changing face of pharmaceutical advertising. A look at medical journals reveals a new era in advertising.
    Weeks WB; Wallace AE; Kimberly BC
    Mark Health Serv; 2001; 21(3):27-30. PubMed ID: 11525138
    [No Abstract]   [Full Text] [Related]  

  • 12. More on the LIFE study.
    Vandenbroucke JP
    Lancet; 2003 Feb; 361(9356):532-3; author reply 533-4. PubMed ID: 12583976
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rules of the game in drug marketing].
    Palva E
    Duodecim; 1999; 115(20):2187, 2189. PubMed ID: 11973920
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preventing stroke. Which antihypertensive drugs can do it better?].
    Böhm S
    MMW Fortschr Med; 2002 Jul; 144(29-30):14-5. PubMed ID: 12219605
    [No Abstract]   [Full Text] [Related]  

  • 15. PMAC code of marketing practices.
    Lexchin J
    CMAJ; 1999 Jun; 160(11):1556. PubMed ID: 10447368
    [No Abstract]   [Full Text] [Related]  

  • 16. More on the LIFE study.
    Werkö L
    Lancet; 2003 Feb; 361(9356):532; author reply 533-4. PubMed ID: 12583975
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

  • 18. [The double messages about atenolol must be an issue for the SBU board].
    Werkö L; Enkvist C
    Lakartidningen; 2004 Dec; 101(49):4038, 4041; discussion 4041-2, 4045. PubMed ID: 15633347
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical journals, academia, and industry-sponsored clinical trials.
    Frighi V
    PLoS Med; 2005 Jul; 2(7):e218. PubMed ID: 16033312
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical journals are an extension of the marketing arm of pharmaceutical companies.
    Smith R
    PLoS Med; 2005 May; 2(5):e138. PubMed ID: 15916457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.